LOS ANGELES --(BUSINESS WIRE)--Jan. 7, 2025-- Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announced today that John S. Yu , M.D., Chief Executive Officer, and Neil Bhowmick , Chief Scientific Officer, will present a corporate overview at the Lytham Partners
